HIPRA made its debut at Aqua Nor 2025, the world’s largest aquaculture technology exhibition, held this year from September 19 to 21 at Trondheim Spektrum in Trondheim, Norway.

Held biennially in that city, Aqua Nor is a key international event for the aquaculture industry, attracting more than 25,000 attendees from over 80 countries. The event serves as a global meeting point where leading industry stakeholders gather to explore the latest innovations and exchange knowledge, all with the goal of advancing a more sustainable aquaculture sector.

HIPRA’s participation comes on the heels of the launch of ICTHIOVAC® ERM, the company’s first inactivated vaccine for Atlantic salmon against Yersiniosis, marking a significant milestone in HIPRA’s entry into the European salmon market. 

With its presence at Aqua Nor 2025, HIPRA reaffirms its commitment to driving progress in fish health and productivity in the salmon industry. The company continues to prioritize innovation, sustainability, and animal welfare, helping to secure a brighter, more resilient future for global aquaculture.